Economic results of a palivizumab seasonal prophylaxis using a cohorting software and vial sharing
<p>Abstract</p> <p>Background</p> <p>Respiratory syncytial virus is the most important pathogen in lower respiratory tract infection in infants and young children. In high-risk populations it may develop severe, sometimes fatal, lower respiratory tract infections. A pro...
Saved in:
Main Authors: | Coletta Elio (Author), Coppolino Salvatore (Author), Federico Febronia (Author), Fulia Francesco (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina
by: Suada Heljic, et al.
Published: (2016) -
Reappraisal of the Subtropical Guidelines on Palivizumab Prophylaxis in Congenital Heart Disease
by: Shuenn-Nan Chiu, et al.
Published: (2022) -
Respiratory infections in children up to two years of age on prophylaxis with palivizumab
by: Ana Isabel M. P. Monteiro, et al.
Published: (2014) -
A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
by: Griffin M Pamela, et al.
Published: (2010) -
ANALYSIS OF HOSPITAL ANTIBIOTIC PRESCRIPTIONS AFTER THE IMPLEMENTATION OF STEWARDSHIP: A RETROSPECTIVE OBSERVATIONAL STUDY IN TWO HOSPITALS IN NORTH-EASTERN SICILY
by: Salvatore Coppolino, et al.
Published: (2023)